The US linkurl:Food and Drug Administration; suffers from "serious scientific deficiencies," potentially compromising the agency's ability to protect the health and safety of consumers, a linkurl:report; by the FDA's science board has concluded. The agency has had the most trouble regulating areas such as linkurl:systems biology,; nanotechnology, and linkurl:regenerative medicine.; The report, commissioned by the FDA's commissioner linkurl:Andrew von Eschenbach; and released last week, states in bold font: "The FDA cannot fulfill its mission because its scientific base has eroded and its scientific organizational structure is weak." The cause, according to the report, is a linkurl:lack of financial support,; inadequate information technology, and too few staff members. The __New York Times__ today linkurl:got no more comment; from the FDA than that the agency "values the evaluation." To solve the "crisis" at the FDA, the board recommends better infrastructure for sharing data, more external collaborations, better staff recruitment, and, of course,...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?